Setting 
My Cart

Ordered before 17:30, shipped today - Support: (012) 800 456 789

Track Your Order

Toggle Nav
mobile icon
Close
  • Menu
  • Setting
  • Home
  • Search results for: 'cpp1 7 npy19 23 ala31 aib32 gln34 hpancreatic polypeptide'

Search results for: 'cpp1 7 npy19 23 ala31 aib32 gln34 hpancreatic polypeptide'

Items 131-140 of 190

Page
per page
  1. Entrectinib
    B5859 Entrectinib
    Target: Trk Receptors|ALK|ROS1
    Summary: Orally active inhibitor of ALK kinase
      ≥28.05 mg/mL
  2. Fruquintinib(HMPL-013)
    B5864 Fruquintinib(HMPL-013)
    Target: VEGFR
    Summary: Potent and selective inhibitor of VEGFR 1, 2, 3
      insoluble in H2O; insoluble in EtOH; ≥6.35 mg/mL
  3. Spautin-1
    B5873 Spautin-1
     1 Citation
    Target: Deubiquitinating enzymes (DUBs)|Autophagy
    Summary: Novel autophagy inhibitor
      insoluble in H2O; ≥13.5 mg/mL
  4. RI-2
    B5881 RI-2
    Target: RAD51
    Summary: Optimized reversible RAD51 inhibitor
      ≥21.65 mg/mL
  5. MnTBAP Chloride
    B5964 MnTBAP Chloride
    Target: Peroxynitrite
    Summary: Cell-permeable superoxide dismutase mimetic
      ≥25.4 mg/mL
  6. CCT251545
    B5979 CCT251545
    Summary: Orally bioavailable and potent WNT signaling inhibitor
      ≥42.2 mg/mL
  7. VR23
    B6026 VR23
    Target: Proteasome
    Summary: proteasome inhibitor
      insoluble in EtOH; insoluble in H2O; ≥45.55 mg/mL
  8. Sulforaphane
    C4733 Sulforaphane
    Summary: inducer of chemopreventative enzymes via Keap1-Nrf2 signaling
      ≥51.6 mg/mL
  9. TPPU
    C5414 TPPU
    Target: epoxide hydrolase
    Summary: potent inhibitor of both human and mouse sEH
      ≥120 mg/mL
  10. AZ 10606120 dihydrochloride
    B5410 AZ 10606120 dihydrochloride
    Target: P2X Receptors
    Summary: Potent P2X7 receptor antagonist
      <12.39 mg/mL

Items 131-140 of 190

Page
per page
Shop By
Now Shopping by
  1. Reported Experiments Animal Experiments Remove This Item
Clear All
Shopping Options
Category
  1. Signaling Pathways 178item
  2. Natural Products 5item
  3. Kits 1 item
  4. Lab Reagents 6item
Specificity
  1. Selective 133item
  2. Non-Selective 2item
Reversibility
  1. Reversible 7item
  2. Irreversible 4item
Target
  1. Caspases 2item
  2. Cyclin-Dependent Kinases 5item
  3. Proteasome 4item
  4. Cathepsins 1 item
  5. Histone Deacetylases (HDACs) 9item
  6. PI3K 7item
  7. CXCR 1 item
  8. Raf 5item
  9. CSF-1R 1 item
  10. EZH2 1 item
  11. mTOR 1 item
  12. MMP 1 item
  13. Androgen Receptors 1 item
  14. Peptidylprolyl isomerases 1 item
  15. FLT3 2item
  16. GSK-3 2item
  17. Factor Xa 1 item
  18. LPA Receptors 1 item
  19. PLK 1 item
  20. VEGFR 8item
  21. PDGFR 4item
  22. c-Kit 2item
  23. RET 1 item
  24. Thymidylate Synthase 1 item
  25. p38 2item
  26. JNK 1 item
  27. MEK 1 item
  28. FGFR 4item
  29. Nrf2 1 item
  30. Liver X receptors (LXRs) 1 item
  31. Voltage-gated Sodium (NaV) Channels 1 item
  32. Deubiquitinating enzymes (DUBs) 2item
  33. PP1 1 item
  34. PP2A 1 item
  35. Eukaryotic elongation factors 1 item
  36. Neuraminidases (NA) 1 item
  37. MET 3item
  38. Src 1 item
  39. Trk Receptors 3item
  40. NMDA Receptors 1 item
  41. STAT 1 item
  42. Microtubules/Tubulins 2item
  43. Estrogen and Related Receptors 2item
  44. EGFR 3item
  45. Reverse Transcriptases 1 item
  46. ROCK 2item
  47. BTK 1 item
  48. RIP kinases 1 item
  49. JAK 1 item
  50. EZH1 1 item
  51. HSP90 1 item
  52. Angiotensin AT2 Receptors 1 item
  53. Topoisomerases 6item
  54. Cytochrome P450 (CYP450) 1 item
  55. M3 Receptors 1 item
  56. S6 kinases 1 item
  57. Toll-like receptors (TLRs) 2item
  58. Adenosine Kinases 1 item
  59. Actin 1 item
  60. Serine Proteases 1 item
  61. Survivin 1 item
  62. ERK 1 item
  63. HMG-CoA Reductases 1 item
  64. c-MET 3item
  65. PKC 2item
  66. Calpains 1 item
  67. Ubiquitin-specific proteases 1 item
  68. RAD51 1 item
  69. Trypsins 1 item
  70. HER2 3item
  71. 5-HT2 Receptors 1 item
  72. DGAT 1 item
  73. Insulin and Insulin-like Receptors 1 item
  74. PARP 1 item
  75. CB1 Receptors 1 item
  76. ALK 4item
  77. ROS1 1 item
  78. NK1 Receptors 1 item
  79. Dehydrogenase 1 item
  80. PKG 1 item
  81. PKA 1 item
  82. Myosin light chain kinases (MLCKs) 2item
  83. HIV-1 gp120 1 item
  84. D1 and D5 Receptors 1 item
  85. D2 Receptors 2item
  86. 5-HT1 Receptors 1 item
  87. 5-HT7 Receptors 1 item
  88. 5-HT3 Receptors 1 item
  89. Angiotensin-Converting Enzymes (ACEs) 1 item
  90. Autophagy 1 item
  91. COX 4item
  92. Pregnane X Receptors 1 item
  93. Squalene epoxidases 1 item
  94. GpIIb/IIIa receptor 1 item
  95. Peroxynitrite 1 item
  96. P2X Receptors 1 item
  97. Ron 1 item
  98. Synthases/Synthetases 1 item
  99. Histamine H1 Receptors 1 item
  100. Phospholipases 1 item
  101. IL Receptors 1 item
  102. CCL2 1 item
  103. Noradrenaline reuptake 1 item
  104. Calcium-Activated Potassium (KCa) Channels 1 item
  105. AChE 1 item
  106. cAMP 1 item
  107. Sulfonylurea receptors 1 item
  108. Peptidoglycan synthesis 1 item
  109. Nuclear Receptors 1 item
  110. Catechol O-Methyltransferase (COMT) 1 item
  111. Angiotensin AT1 Receptors 1 item
  112. Hydroxylases 1 item
  113. DREADD Ligands 1 item
  114. PP4 1 item
  115. AChR 1 item
  116. Fyn kinase 1 item
  117. Ub-conjugating enzyme (E2) complex 1 item
  118. PPAR 2item
  119. IKK 1 item
  120. PC-PLC 1 item
  121. Antibiotic 1 item
  122. Hec1 1 item
  123. ErbB-2 1 item
  124. adrenergic receptor 1 item
  125. TRPA 1 item
  126. Histone Acetyltransferases (HATs) 1 item
  127. Tyrosinases 1 item
  128. ITK 1 item
  129. NUAK 1 item
  130. SERT 1 item
  131. prolactin secretion 1 item
  132. gonadotropin release 1 item
  133. 5-HT receptor 1 item
  134. 5-alpha Reductases 1 item
  135. NOP Receptors 1 item
  136. Transferases 1 item
  137. Dopamine receptor 1 item
  138. Histamine receptor 1 item
  139. DHFR 1 item
  140. GARFT 1 item
  141. PRMT 1 item
  142. epoxide hydrolase 1 item
  143. Serotonin (5-HT) reuptake 1 item
  144. NE 1 item
  145. PIKfyve 1 item
Related Disease
  1. Acute Myelogenous Leukemia 2item
  2. Acute Myeloid Leukemia 2item
  3. Adrenocortical Carcinoma 1 item
  4. Anesthesia 1 item
  5. Bladder Cancer 3item
  6. B-lymphoid Malignancies 1 item
  7. Brain Injuries Studies 1 item
  8. Breast Cancer 20item
  9. Cancer 88item
  10. Chronic Lymphocytic Leukemia 2item
  11. Cocaine-Related Disorders 1 item
  12. Colon Cancer 9item
  13. Colorectal Cancer 10item
  14. Depression 1 item
  15. Diabetes 3item
  16. Glioblastoma 7item
  17. Glioma 5item
  18. Hepatocellular Carcinoma 3item
  19. HIV 2item
  20. Inflammatory Diseases 2item
  21. Lung Cancer 5item
  22. Lung Carcinoma 2item
  23. Lymphoma 6item
  24. Mantle Cell Lymphoma 2item
  25. Melanoma 7item
  26. Multiple Myeloma 5item
  27. Myeloma 2item
  28. Neuroblastoma 4item
  29. Neurocognitive Disorders 1 item
  30. Non-small Cell Lung Cancer 5item
  31. Obsessive-Compulsive Disorder 1 item
  32. Osteoporosis 1 item
  33. Ovarian Cancer 5item
  34. Pancreatic Cancer 8item
  35. Prostate Cancer 6item
  36. Renal Cancer 1 item
  37. Renal Cell Carcinoma 2item
  38. Rheumatoid Arthritis 1 item
  39. Schizophrenia 3item
  40. Thyroid Cancer 1 item
  41. Type 2 Diabetes 2item